SZSE Ticker: 300158

Shanxi Zhendong Pharmaceutical Co., Ltd

山西振东制药股份有限公司

振东制药

ZHENDONG PHARMACY

Listing Date: 2011-01-07

Board: GEM

Industry Classification: Manufacturing

Zhendong Pharmaceutical: The company has not planted vines

Post date May 17, 2022 — 10:33 Post Lock

Hepatitis concept, new crown treatment, traditional Chinese medicine and other pharmaceutical stocks fell

Post date May 17, 2022 — 10:27 Post Lock

Zhendong Pharmaceutical: Filling the blank of Chinese medicine industry standards and realizing the rapid development of Chinese medicine industry

Post date May 16, 2022 — 13:32 Post Lock

Zhendong Pharma helps the front line of Shanghai's anti-epidemic efforts and works together to keep "Shanghai"

Post date May 16, 2022 — 13:14 Post Lock

Dividend Yield Ranking: 141 stocks have a dividend yield of over 3% for three consecutive years _ Oriental Fortune Net

Post date May 16, 2022 — 10:06 Post Lock

"Smart money" doomsday return to start "bottom-hunting mode" This week's northbound fund sweeping list is here! -Stock Channel-Hexun.com

Post date May 15, 2022 — 10:25 Post Lock

The first bioeconomy five-year plan emphasizes the quality of traditional Chinese medicine Zhendong Pharmaceutical fills the gap in industry standards

Post date May 14, 2022 — 17:17 Post Lock

The first bioeconomy five-year plan emphasizes the quality of traditional Chinese medicine Zhendong Pharmaceutical fills the gap in industry standards

Post date May 14, 2022 — 00:19 Post Lock

The pharmaceutical and biological industry has a net outflow of 2.855 billion yuan today, and the net outflow of 6 shares exceeds 100 million yuan.

Post date May 13, 2022 — 19:02 Post Lock

Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline

Post date May 13, 2022 — 11:03 Post Lock

Dividend Yield Ranking: 141 stocks have a dividend yield of over 3% for three consecutive years _ Securities Times

Post date May 13, 2022 — 10:43 Post Lock

Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com

Post date May 13, 2022 — 08:55 Post Lock

Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years

Post date May 13, 2022 — 08:50 Post Lock

Dividend Yield Ranking: 141 stocks have a dividend yield of over 3% for three consecutive years _ Oriental Fortune Net

Post date May 12, 2022 — 11:05 Post Lock

3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews

Post date May 11, 2022 — 20:54 Post Lock

2.389 billion yuan of main funds withdraw from the pharmaceutical and biological sector today_ Oriental Fortune Net

Post date May 10, 2022 — 18:18 Post Lock

[Transaction stock] The hepatitis concept sector fell, and Shuangcheng Pharmaceutical (002693.CN) fell 6.63%-Hong Kong Stocks-Financial

Post date May 9, 2022 — 12:30 Post Lock

Shanghai and Shenzhen stock market trading tips (May 9)

Post date May 9, 2022 — 09:00 Post Lock

Which strong industrial and commercial bank has over 100 billion cash dividends

Post date May 9, 2022 — 07:31 Post Lock

National Health Commission: my country has not found any cases of acute hepatitis of unknown cause in children

Post date May 7, 2022 — 22:24 Post Lock

Want to see more data? Registered subscribers can see all the data.